Realizing our “Triple-A Mandate”
Four years ago, TB Alliance secured the first regulatory approval from the United States Food and Drug Administration (US FDA) […]
Press Releases
TB Alliance Announces Partnership with Remington Pharmaceuticals to Commercialize New Therapy for Drug-Resistant Forms of TB in Pakistan
NEW YORK (August 10, 2023)—Non-profit drug developer TB Alliance has granted Remington Pharmaceutical Industries (Pvt.) Ltd. a non-royalty bearing license
News
TB Alliance Statement on Johnson & Johnson Agreement with Stop TB/GDF
NEW YORK (July 28, 2023)—TB Alliance applauds all efforts to expand access responsibly to lifesaving TB technologies. Stimulating market competition
Pretomanid’s Addition to the WHO’s Essential Medicine List Enhances Access to All Oral, Six-Month DR-TB Therapy
“The addition of pretomanid to the Essential Medicines List (EML) of the World Health Organization (WHO) is a critical step
Germany’s Federal Ministry of Education and Research (BMBF) Grants Funding to Advance the Fight Against Poverty-Related and Neglected Tropical Diseases
BERLIN (7 July 2023)—The German Federal Ministry of Education and Research (BMBF) through KfW has granted funding to five non-profit
TB Alliance receives up to $3.9M from the Cystic Fibrosis Foundation to further the development of an NTM drug
NEW YORK (May 17, 2023)—TB Alliance today announces that it will receive up to $3.9 million from the Cystic Fibrosis
TB Alliance Statement on United Nations Multi-Stakeholder Hearing on Tuberculosis
TB Alliance urges world leaders to unleash the power of science and the best qualities of humanity to end TB.
Ratan P. Watal Appointed to the Board of TB Alliance
New Delhi, March 10th, 2023: TB Alliance, a New York-based global not-for-profit organization, has appointed Ratan P. Watal to its Board
TB Alliance Announces David Norton as Board Chair
NEW YORK (February 23, 2023)—The TB Alliance Board of Directors has elected David Norton as Chairperson of the Board. In
Fireside Chat with Bruce Carter
We spoke with Bruce Carter, outgoing Chair of the TB Alliance Board of Directors, about his seventeen years serving as